Mukul Agrawal's Top 2 Stock Picks Show Impressive Gains, Investor Focus for 2026

INDUSTRIAL-GOODSSERVICES
Whalesbook Logo
AuthorAbhay Singh|Published at:
Mukul Agrawal's Top 2 Stock Picks Show Impressive Gains, Investor Focus for 2026
Overview

Super investor Mukul Agrawal, founder of Param Capital Group, has added two stocks – Tatva Chintan Pharma Chem Ltd and Monolithisch India Ltd – to his portfolio, which have already delivered impressive returns of 81% and 140% this year respectively. These companies, operating in specialty chemicals/pharma and industrial materials, are showing signs of turnaround and strong growth, making them key watchpoints for investors targeting 2026.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Mukul Agrawal, a prominent figure in Indian investment circles, often referred to as the 'Warren Buffett of India' for his bold investment strategies, heads the Param Capital Group. He currently holds a significant portfolio of stocks.

Two particular companies that have caught the attention of smart investors are Tatva Chintan Pharma Chem Ltd and Monolithisch India Ltd, both of which Agrawal has invested in.

Tatva Chintan Pharma Chem Ltd
This company, incorporated in 1996, is a manufacturer of a diverse portfolio including Structure Directing Agents, Phase Transfer Catalysts, electrolyte salts for batteries, and Pharmaceutical and Agrochemical Intermediates, among other specialty chemicals. It boasts a market capitalization of Rs 3,647 crore.

Financial Performance:
Sales have grown at a compound rate of 8% in the last five years (FY20-FY25). While EBITDA and net profits saw a drop from FY20 to FY25, the first half of the current fiscal year (Apr-Sep 2025) shows improved figures, indicating a potential turnaround.

Stock Performance:
The share price of Tatva Chintan Pharma Chem Ltd jumped 81% from January 2025 to mid-November 2025.

Valuation:
The stock is trading at a high Price-to-Earnings (PE) ratio of 205x, significantly above the industry median of 30x.

Outlook:
According to recent investor presentations, Tatva Chintan is exiting a prolonged downcycle with clear traction across high-barrier verticals like SDA, Electrolytes, and Semiconductors.

Monolithisch India Ltd
Incorporated in 2018, Monolithisch India Ltd manufactures and supplies premixed high-quality ramming mass, a crucial heat insulation and lining material for Induction furnaces used in the iron, steel, and foundry sectors. It has a market capitalization of Rs 1,251 crore.

Performance:
The company has demonstrated robust growth. Sales have grown at a compounded rate of 81% from FY20 to FY25, and EBITDA at 84% CAGR. Net profits have shown a remarkable 114% CAGR growth, turning from zero profit in FY20 to Rs 14 crore in FY25.

Stock Performance:
Since its listing in June 2025, the share price of Monolithisch India has surged 140% by mid-November 2025.

Valuation & Efficiency:
The stock trades at a PE of 71x, above the industry median. Notably, it boasts a Return on Capital Employed (ROCE) of 61%, vastly outperforming the industry median of 17%.

Outlook:
The Executive Director projects sustained momentum with a revenue CAGR of 60% projected for FY25-FY28.

Impact
This news is likely to impact Indian investor sentiment, drawing attention to these two specific stocks and the investment philosophy of following prominent investors like Mukul Agrawal. It could lead to increased interest in the specialty chemicals and industrial materials sectors.
Rating: 7/10

Difficult Terms

  • Structure Directing Agents (SDA): Chemicals used to synthesize specific molecular structures, particularly in the production of zeolites, which are vital catalysts in the petrochemical industry.
  • Phase Transfer Catalysts: Compounds that enable chemical reactions between substances that are not typically soluble in the same solvent (e.g., water and oil).
  • Electrolyte Salts: Salts that, when dissolved in a solvent, form an electrolyte solution essential for the functioning of batteries, especially in electric vehicles.
  • Pharmaceutical Intermediates: Chemical compounds that serve as building blocks in the synthesis of active pharmaceutical ingredients (APIs) for medicines.
  • Agrochemical Intermediates: Chemical compounds used as precursors in the manufacturing of pesticides, herbicides, and other agricultural chemicals.
  • Speciality Chemicals: High-value chemicals produced for specific applications, offering distinct performance characteristics.
  • EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization): A measure of a company's operating profitability before accounting for financing costs, taxes, and non-cash charges like depreciation and amortization.
  • Net Profits: The final profit of a company after all expenses, including interest, taxes, depreciation, and amortization, have been deducted from revenue.
  • PE Ratio (Price-to-Earnings Ratio): A valuation metric that compares a company's stock price to its earnings per share. A higher ratio often suggests higher growth expectations or potential overvaluation.
  • Ramming Mass: A refractory material used as a lining in furnaces, particularly induction furnaces, to withstand high temperatures in the steel and metal industries.
  • Induction Furnaces: Electric furnaces that use electromagnetic induction to heat and melt materials, commonly employed in metal smelting and refining.
  • ROCE (Return on Capital Employed): A financial ratio that indicates how efficiently a company is using its capital to generate profits. A higher ROCE suggests better capital management.
  • CAGR (Compound Annual Growth Rate): The average annual growth rate of an investment over a specified period, assuming that profits are reinvested.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.